Care Step Pathway Tools for Immune-Related Adverse Event Assessment and Management

Abstract

This article is a part of a JADPRO certified supplement, Immuno-Oncology Therapy Essentials: Proactive Management of Immune-Related Adverse Events

Table of Contents

1. Immuno-Oncology Essentials: An Overview
2. Meeting the Challenge of Immune-Related Adverse Events With Optimized Telephone Triage and Dedicated Oncology Acute Care
3. PD-1/PD-L1 Inhibitors for Non–Small Cell Lung Cancer: Incorporating Care Step Pathways for Effective Side-Effect Management
4. Checkpoint Inhibitor Immunotherapy for Head and Neck Cancer: Incorporating Care Step Pathways for Effective Side-Effect Management
5. Immune-Related Adverse Events From Immunotherapy: Incorporating Care Step Pathways to Improve Management Across Tumor Types
6. Appendix: Care Step Pathway Tools for Immune-Related Adverse Event Assessment and Management (current article)

Note: The skin toxicities pathway has been modified to remove specific dosages for topical corticosteroids. These were erroneously listed in mg/kg (rather than %).